Delayed Melanoma Care During Pandemic Proved Costly
Delayed diagnoses due to pandemic lockdowns tied to years of life lost
Observed Rates of Cancer Diagnoses Lower Than Expected in Pandemic
Rate of all-sites cancer incidence was 28.6 percent lower than expected during the height of the COVID-19 pandemic response
Level of Burnout Higher for Women in Health Care Occupations
Gender-specific factors that have direct link to well-being include job satisfaction, psychological health, and work-life integration
Jill Biden Announces $100 Million for Research on Women’s Health
Clinical Markers Improve With IV Ertapenem for Hidradenitis Suppurativa
Significant reductions seen in mean Physician Global Assessment scores and in pain, C-reactive protein, IL-6, leukocytes
This Election Year, Health Care Costs Top Voter Concerns: Poll
Amtagvi Approved by the FDA for Treatment of Advanced Melanoma
Agency approves one-time cell therapy for patients who have progressed after initial standard-of-care therapies
Expanded Use of Xolair to Treat Food Allergies Approved by the FDA
Xolair is not meant to substitute for emergency anaphylaxis medications such as the EpiPen
Deep Learning Improves Diagnostic Accuracy for Skin Diseases
Both specialists and generalists were 4 percentage points less accurate for diagnosis of images of dark versus light skin
FDA Approves Aurlumyn for Severe Frostbite
Newly approved medication lowers the need for amputation of fingers or toes
